• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Drug Infusion System Market

    ID: MRFR/MED/18375-HCR
    100 Pages
    Garvit Vyas
    October 2025

    US Drug Infusion System Market Research Report By Product Type (Elastomeric Infusion System, Disposable Infusion System), By Application (Oncology/Chemotherapy), By Mode of Administration (Intravenous) and By End User (Hospitals) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Drug Infusion System Market Infographic
    Purchase Options

    US Drug Infusion System Market Summary

    The US Drug Infusion System market is projected to grow from 12.5 USD Billion in 2024 to 20.3 USD Billion by 2035.

    Key Market Trends & Highlights

    US Drug Infusion System Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 4.51 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 20.3 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 12.5 USD Billion, reflecting a solid foundation for future expansion.
    • Growing adoption of advanced drug delivery technologies due to increasing patient demand is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.5 (USD Billion)
    2035 Market Size 20.3 (USD Billion)
    CAGR (2025 - 2035) 4.51%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    US Drug Infusion System Market Trends

    The US Drug Infusion System Market is experiencing significant trends shaped by technological advancements and the increasing focus on patient care. One major market driver is the growing prevalence of chronic diseases, such as diabetes and cancer, which require frequent and precise drug administration. This trend is pushing healthcare providers to adopt advanced infusion systems that enhance medication delivery efficiency and reduce the risk of errors.

    Additionally, there is a trend towards integrated delivery systems that allow healthcare professionals to monitor patients remotely, thus improving treatment outcomes and offering a higher level of convenience for patients. Opportunities in this market are emerging from the demand for personalized and automated infusion devices. As patients increasingly seek solutions that cater to their specific medical needs, manufacturers can explore innovations in smart infusion devices that provide real-time data and adjust dosages based on patient conditions.

    Furthermore, changes in healthcare regulations in the US, promoting more thorough evaluations of medical devices, can pave the way for new market entrants and foster healthy competition, pushing innovation. In recent times, there has also been a shift towards outpatient treatments and home healthcare, driven by the need for cost-effectiveness and patient comfort. Government policies supporting telehealth services further support this trend, leading to a higher demand for portable infusion systems.

    Consequently, the landscape of the drug infusion system market in the US is complex but full of potential, defining the way medications are administered and monitored within diverse healthcare settings. As compliance with digital health standards continues to rise, the focus on drug infusion systems is likely to grow, presenting numerous possibilities for stakeholders within the marketplace.

    Market Segment Insights

    Drug Infusion System Market Product Type Insights

    The US Drug Infusion System Market is exhibiting considerable growth and innovation, largely driven by the evolving needs of healthcare providers and patients. Within this market, the Product Type segment displays diverse offerings that cater to various clinical applications. Elastomeric Infusion Systems are particularly gaining traction due to their ability to provide continuous drug delivery without the need for external power sources.

    This self-contained system typically utilizes elastomeric materials to allow controlled drug infusion over an extended period, making it ideal for outpatient settings and reducing the burden on healthcare facilities. The convenience and effectiveness in pain management and chemotherapy applications are key factors contributing to its increasing adoption. Disposable Infusion Systems also play a significant role in the market, offering a critical solution for maintaining hygiene and minimizing the risk of infections.

    Their one-time use eliminates the need for complex cleaning and sterilization processes, streamlining operations in hospitals and clinics. As healthcare focuses more on patient safety and infection control, the demand for disposable systems is bolstering their importance in the US Drug Infusion System Market landscape. Additionally, the trend toward home healthcare is encouraging developments in these product types, as patients are increasingly treated in their homes, where ease of use and patient empowerment become paramount.

    The combination of these factors indicates that both Elastomeric Infusion Systems and Disposable Infusion Systems are not only significant in terms of revenue potential but also crucial in shaping the future dynamics of the US Drug Infusion System Market.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Drug Infusion System Market Application Insights

    The Application segment of the US Drug Infusion System Market is vital, particularly in the realm of Oncology and Chemotherapy. This segment has gained prominence due to the increasing prevalence of cancer diagnoses across the United States, which underscores the need for effective drug delivery systems. The advancements in technology have led to innovative drug infusion systems that ensure accurate dosing and reduce the likelihood of complications associated with chemotherapy.

    Additionally, growing awareness and demand for personalized medicine are driving the development of tailored solutions in drug infusion, further reinforcing the segment's significance. Furthermore, institutions are investing in Research and Development to enhance the efficacy of drug delivery systems for cancer treatment, addressing patient convenience and improving therapeutic outcomes. As healthcare infrastructure continues to evolve, the focus on improving patient care in oncology remains a priority, making the Oncology and Chemotherapy category a crucial aspect of the US Drug Infusion System Market.

    This segment is expected to maintain its dominance, propelled by ongoing trends that emphasize efficacy and safety in drug administration for patients undergoing cancer treatment.

    Drug Infusion System Market Mode of Administration Insights

    The Mode of Administration segment within the US Drug Infusion System Market plays a crucial role in the overall efficiency and effectiveness of medication delivery. Intravenous administration dominates this segment due to its swift onset of action, making it essential for acute care settings such as hospitals and emergency units. The US Drug Infusion System Market statistics indicate a growing reliance on intravenous methods, especially for patients requiring rapid administration of antibiotics, chemotherapy, and pain management medications.

    The increasing prevalence of chronic diseases and the aging population in the U.S. further fuel the demand for innovative intravenous delivery systems. Enhanced technologies, such as smart infusion pumps, are being integrated to improve medication accuracy and patient safety. Additionally, the ongoing Research and Development efforts focus on optimizing intravenous systems to ensure better patient compliance and therapeutic outcomes.

    However, challenges such as the risks of infection and complications remain prevalent and underline the need for stringent protocols and advanced training for healthcare providers. Thus, intravenous administration not only supports the present healthcare demands but also represents significant opportunities for advancements in drug delivery methodologies within the US landscape.

    Drug Infusion System Market End User Insights

    The US Drug Infusion System Market has seen significant developments in its End User segment, particularly within hospitals, which play a crucial role in healthcare delivery. As the primary setting for the administration of medications via infusion systems, hospitals account for a major share of usage in the market. Factors driving hospital demand include the increasing prevalence of chronic diseases that require long-term medication management, advancements in precision medicine, and the growing focus on patient-centric care.

    Hospitals are integrating advanced drug infusion systems to enhance patient safety and improve treatment efficiency, which aligns with the rising expectations for superior healthcare outcomes. Furthermore, continuous improvements in technology, such as smart infusion pumps that reduce medication errors and promote adherence to dosages, benefit not only clinical workflows but also patient experiences. The ongoing demand for specialized care and the expansion of outpatient services are anticipated to further bolster the importance of drug infusion systems in hospitals across the United States.

    This segment remains vital due to its direct impact on patient care, resource allocation, and overall healthcare efficiency in the US Drug Infusion System Market.

    Get more detailed insights about US Drug Infusion System Market Research Report — Global Forecast till 2035

    Key Players and Competitive Insights

    The US Drug Infusion System Market is a dynamic and rapidly evolving sector characterized by intense competition among various players. The market features an array of advanced technologies and innovative products designed to enhance the safety and efficacy of drug delivery systems. Companies are continuously striving to develop advanced infusion devices that cater to a wide range of healthcare applications, including pain management, chemotherapy, and diabetes care. The competitive landscape is shaped by factors such as technological advancements, regulatory approvals, product launches, and strategic collaborations.

    Companies also focus on adapting to changing healthcare needs and improving patient outcomes while managing costs, resulting in a diverse and competitive marketplace.

    Key Companies in the US Drug Infusion System Market market include

    Industry Developments

    The US Drug Infusion System Market has witnessed significant developments recently, particularly with advancements in technology and patient care solutions. Companies like C.R. Bard and Medtronic are increasingly focusing on innovative infusion systems that enhance patient safety and efficacy. In November 2023, Moog Inc. announced a collaboration aimed at integrating AI-driven solutions into their existing infusion systems, enhancing the precision of drug delivery.

    Additionally, in October 2023, Smiths Medical received FDA clearance for their new infusion pump, signaling a strong commitment to advancing infusion therapy standards. Moreover, a notable merger occurred in September 2023 when Becton Dickinson and Company acquired a subsidiary of Eitan Group for improved market access in the US, thereby expanding its capabilities in drug infusion systems.

    The market's valuation has been positively impacted by a rising demand for home healthcare solutions, particularly post-pandemic, with a marked increase in the use of infusion systems for chronic disease management. The growth trajectory of the US Drug Infusion System Market continues to be influenced by increased regulatory support and evolving healthcare needs, creating opportunities for key players like Fresenius Kabi and ICU Medical to expand their product offerings.

    Market Segmentation

    Drug Infusion System Market End User Outlook

    • Hospitals

    Drug Infusion System Market Application Outlook

    • Oncology/Chemotherapy

    Drug Infusion System Market Product Type Outlook

    • Elastomeric Infusion System
    • Disposable Infusion System

    Drug Infusion System Market Mode of Administration Outlook

    • Intravenous

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 2.12(USD Billion)
    MARKET SIZE 2024 2.5(USD Billion)
    MARKET SIZE 2035 3.75(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 3.755% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED C.R. Bard, Smiths Medical, Terumo Corporation, Medtronic, Moog Inc, Horizon Therapeutics, Eitan Group, CSL Behring, Becton Dickinson and Company, B Braun Melsungen AG, Fresenius Kabi, Zyno Medical, Pall Corporation, ICU Medical, Halyard Health
    SEGMENTS COVERED Product Type, Application, Mode of Administration, End User
    KEY MARKET OPPORTUNITIES Rise in chronic disease prevalence, Advancements in infusion technology, Increasing home healthcare demand, Growing geriatric population, Expansion of telehealth services
    KEY MARKET DYNAMICS Aging population, Technological advancements, Increased chronic diseases, Rising home healthcare demand, Market consolidation activities
    COUNTRIES COVERED US

    FAQs

    What is the expected market size of the US Drug Infusion System Market in 2024?

    The US Drug Infusion System Market is expected to be valued at 2.5 billion USD in 2024.

    What is the projected market size of the US Drug Infusion System Market by 2035?

    By 2035, the market is projected to grow to 3.75 billion USD.

    What is the expected CAGR for the US Drug Infusion System Market from 2025 to 2035?

    The expected CAGR for this market from 2025 to 2035 is 3.755 percent.

    What are the expected valuations for the Elastomeric Infusion System by 2035?

    The Elastomeric Infusion System is expected to be valued at 1.8 billion USD by 2035.

    What is the market value forecast for the Disposable Infusion System in 2035?

    The Disposable Infusion System is projected to reach a market value of 1.95 billion USD by 2035.

    Who are the key players in the US Drug Infusion System Market?

    Major players in the market include C.R. Bard, Smiths Medical, Terumo Corporation, and Medtronic.

    What was the market size for Elastomeric Infusion System in 2024?

    In 2024, the market for Elastomeric Infusion System was valued at 1.2 billion USD.

    What is the market growth rate for the Disposable Infusion System from 2025 to 2035?

    The Disposable Infusion System is expected to experience notable growth during the 2025 to 2035 period.

    What are the emerging trends in the US Drug Infusion System Market?

    Emerging trends include increased automation and integration of infusion systems with hospital management software.

    How does the US Drug Infusion System Market compare to other regional markets?

    The US market for Drug Infusion Systems remains one of the largest and most advanced globally, driven by high demand and innovation.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials